ANAPTYSBIO, INC
AnaptysBio is a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics for autoimmune and inflammatory diseases. Their pipeline includes rosnilimab (Phase 2b, RA), ANB033 (Phase 1b, celiac disease), and ANB101 (Phase 1a). They've also out-licensed therapeutic antibodies like Jemperli to GSK and imsidolimab to Vanda Pharmaceuticals. Anaptys plans to separate its biopharma operations from its royalty assets by year-end 2026.
Officiellt Register
Senast verifierad: 12/30/2025
AI Kvalitetsanalys
Förtroendepoäng Detaljer
Snabblänkar
Webbplats Höjdpunkter
🌟 Liknande Pålitliga Företag
Protalix BioTherapeutics, Inc.
Protalix is dedicated to bringing to market recombinant therapeutic proteins with clinically improved profiles, produced with their ProCellEx® plant cell-based expression system. They focus on treating rare diseases and have already launched two enzyme replacement therapies. The company is known for its innovative ProCellEx® technology.
Cidara Therapeutics, Inc.
Cidara Therapeutics develops targeted immunotherapies to save lives and improve the standard of care for patients facing serious diseases. Their Cloudbreak platform creates “single molecule cocktails” designed to inhibit specific disease targets while engaging the immune system. Noted as a Top Place to Work for six years.
Alpha Teknova, Inc.
This company provides a range of solutions and products, mainly focused on AAV (Adeno-Associated Virus) technologies, including PCR sample preparation kits, stabilizers, and AEX buffer screening kits. They also offer a variety of agar plates, bacterial and fungal culture media, buffers, reagents, and cryopreservation media for biological research. Their products are utilized in molecular biology, cell culture, and related scientific fields. They offer RUO and GMP grade products.